These data highlight the pressing need to elucidate the posttranslational mechanisms that regulate NIS expression at the PM, both under physiological and pathological conditions, so as to devise new strategies to restore the RAI uptake by refractory thyroid carcinomas. This evidence concerns the gene SLC5A5 and thyroid gland carcinoma.